Table 2.
Relative risk of overall survival (OS).
Characteristics | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
aHR (95% CI) | p-Value | aHR (95% CI) | p-Value | |
Age, years | ||||
≤65 | Reference | Reference | ||
>65 | 1.52 (0.96–2.42) | 0.076 | – | 0.501 |
Sex | ||||
Male | Reference | Reference | ||
Female | 1.00 (0.51–1.95) | 0.995 | – | 0.867 |
BMI, kg/m2 | ||||
≤24 | Reference | Reference | ||
>24 | 0.78 (0.48–1.26) | 0.300 | – | 0.837 |
CCI | ||||
≤2 | Reference | Reference | ||
>2 | 0.92 (0.58–1.47) | 0.736 | – | 0.227 |
T stage | ||||
T1 | Reference | Reference | ||
T2 | 2.27 (1.10–4.67) | 0.026 | 2.21 (1.08–4.54) | 0.031 |
T3 | 3.81 (1.97–7.39) | <0.001 | 3.37 (1.73–6.56) | <0.001 |
T4 | 5.75 (2.96–11.18) | <0.001 | 4.71 (2.41–9.21) | <0.001 |
N stage | ||||
N0 | Reference | Reference | ||
N+ | 3.40 (2.06-5.61) | <0.001 | – | 0.081 |
M stage | ||||
M0 | Reference | Reference | ||
M1 | 2.88 (1.16–7.19) | 0.023 | – | 0.137 |
Grade | ||||
Low grade | Reference | Reference | ||
High grade | 1.91 (0.69–5.31) | 0.217 | – | 0.846 |
LCR | ||||
Low | Reference | Reference | ||
High | 0.34 (0.21–0.53) | <0.001 | 0.41 (0.26–0.66) | <0.001 |
BMI, body mass index; aHR, adjusted hazard ratio; LCR, lymphocyte–C-reactive protein ratio; CCI, comprehensive complication index.